Abstract
We evaluated the change in transcutaneous oxygen (tcPO2) and carbon dioxide (tcPCO2) tension in response to 60 minutes' infusion of Intralipid (Kabi Vitrum (Saphar)) (mean dose 0,16 ± 0,07 g/kg/h) in neonates with lung disease (hyaline membrane disease or bronchopulmonary dysplasia). The tcPO2 was 10% lower following Intralipid infusion (P < 0,05), whereas no significant change occurred in tcPO2 measurements. The data confirm the need for limited use of Intralipid in this category of patients.
Original language | English |
---|---|
Pages (from-to) | 389-391 |
Number of pages | 3 |
Journal | South African Medical Journal |
Volume | 72 |
Issue number | 6 |
Publication status | Published - 1987 |
Externally published | Yes |